BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8

• Press Releases

  CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

  July 3, 2025

   · 

  8 min read
• Press Releases

  Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

  July 3, 2025

   · 

  7 min read
• Press Releases

  BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

  July 3, 2025

   · 

  4 min read
• Press Releases

  Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

  July 3, 2025

   · 

  7 min read
• Press Releases

  VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

  July 3, 2025

   · 

  7 min read
• Press Releases

  Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism

  July 3, 2025

   · 

  1 min read
• Press Releases

  Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)

  July 3, 2025

   · 

  9 min read
• Press Releases

  Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaboration Selected to Advance into IND-Enabling Studies

  July 3, 2025

   · 

  3 min read
• Press Releases

  Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan

  July 3, 2025

   · 

  2 min read
• Press Releases

  Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team

  July 3, 2025

   · 

  2 min read